Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Paediatric asthma and pneumococcal vaccination.

Esposito S, Musio A, Principi N.

Vaccine. 2013 Oct 17;31(44):5015-9. doi: 10.1016/j.vaccine.2013.08.090. Review.

PMID:
24021307
2.
3.

Paediatricians' perspectives on the use of pneumococcal vaccine in healthy and asthmatic children.

Karakaş T, Şahiner UM, Soyer OU, Civelek E, Cokugras H, Şekerel BE.

Allergol Immunopathol (Madr). 2010 Sep-Oct;38(5):241-5. doi: 10.1016/j.aller.2009.12.005.

PMID:
20656396
4.

Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.

Zangeneh TT, Baracco G, Al-Tawfiq JA.

Expert Rev Vaccines. 2011 Mar;10(3):345-53. doi: 10.1586/erv.11.1. Review.

PMID:
21434802
5.

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.

Vestrheim DF, Løvoll O, Aaberge IS, Caugant DA, Høiby EA, Bakke H, Bergsaker MR.

Vaccine. 2008 Jun 19;26(26):3277-81. doi: 10.1016/j.vaccine.2008.03.087.

PMID:
18456376
6.
7.
8.

The pneumococcal conjugate vaccine.

Jacobson RM, Poland GA.

Minerva Pediatr. 2002 Aug;54(4):295-303. Review.

PMID:
12131865
9.

Call to action on pneumococcal disease: review of vaccination evidence and outcomes of webcast programs.

Grogg SE, Schultz J.

J Am Osteopath Assoc. 2015 Jun;115(6 Suppl):S6-25. doi: 10.7556/jaoa.2015.071. Review.

PMID:
26000904
10.

The potential of pneumococcal conjugate vaccines for children.

Whitney CG, Pickering LK.

Pediatr Infect Dis J. 2002 Oct;21(10):961-70. Review.

PMID:
12394822
11.

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L.

BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. Review.

12.

Pneumococcal infections: association with asthma and COPD.

Obert J, Burgel PR.

Med Mal Infect. 2012 May;42(5):188-92. doi: 10.1016/j.medmal.2012.02.003. Review.

PMID:
22444165
15.

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B.

Pediatr Infect Dis J. 2004 Jun;23(6):485-9.

PMID:
15194827
16.

Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children.

Paradiso PR.

Clin Infect Dis. 2011 May;52(10):1241-7. doi: 10.1093/cid/cir142. Review.

17.

Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants.

Knuf M, Pankow-Culot H, Grunert D, Rapp M, Panzer F, Köllges R, Fanic A, Habib A, Borys D, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2012 Jan;31(1):e31-6. doi: 10.1097/INF.0b013e3182323ac2.

PMID:
21909049
18.

Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.

Vila-Corcoles A, Ochoa-Gondar O.

Expert Rev Vaccines. 2012 Feb;11(2):221-36. doi: 10.1586/erv.11.176. Review.

PMID:
22309670
19.

Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).

Centers for Disease Control and Prevention (CDC).; Advisory Committee on Immunization Practices..

MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6.

20.

[Serious invasive pneumococcal disease in young children: the importance of vaccination].

Haveman LM, Geelen SP, Sanders EA, Wolfs TF.

Ned Tijdschr Geneeskd. 2002 Oct 12;146(41):1917-20. Dutch.

PMID:
12404904
Items per page

Supplemental Content

Support Center